LIMK1 IHC scores were also significantly higher in stage III compared with stage II (P = 0.0068) tumor (Fig. 4D), suggesting that LIMK1 is closely associated with the malignant progression of BC. The gene discussed is LIMK1; the disease is breast cancer.